KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$94.11
+5.77 (+6.53%)
Performance
1D
—
1W
+2.03%
1M
+20.72%
3M
+22.97%
6M
+61.23%
1Y
+143.62%
YTD
+124.04%
Open$88.96
Previous Close$88.34
Day High$94.32
Day Low$88.41
52W High$98.36
52W Low$36.56
Volume—
Avg Volume1.10M
Market Cap7.25B
P/E Ratio89.85
EPS$0.98
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$79.99
Above
SMA 200
$61.01
Above
RSI (14)
64.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-22.8% upside
Current
$94.11
$94.11
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 636.66M | 437.72M | 434.64M |
| Net Income | 55.44M | 34.31M | -80,259,876 |
| Profit Margin | 8.7% | 8.3% | -18.5% |
| EBITDA | 74.02M | 48.34M | -90,838,119 |
| Free Cash Flow | — | — | -118,111,706 |
| Rev Growth | +45.5% | +45.5% | +6.7% |
| Debt/Equity | — | — | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |